Gynecology

Articles

• 2018. Colombo N et al. – Evaluation of a Streamlined Oncologist-Led BRCA Mutation Testing and Counseling Model for Patients With Ovarian Cancer
• 2017. Rosen VM et al – Systematic Review and Network Meta-Analysis of Bevacizumab Plus First-Line Topotecan-Paclitaxel or Cisplatin-Paclitaxel Versus Non-Bevacizumab-Containing Therapies in Persistent, Recurrent, or Metastatic Cervical Cancer
• 2017. Zanotti G et al. – Treatment patterns and real world clinical outcomes in ER+/HER2- post-menopausal metastatic breast cancer patients in the United States
• 2014. Panagiotopoulou N et al. – Uterine-sparing minimally invasive interventions in women with uterine fibroids: A systematic review and indirect treatment comparison meta-analysis
• 2014. Cope S et al. – A process for assessing the feasibility of a network meta-analysis: A case study of everolimus in combination with hormonal therapy versus chemotherapy for advanced breast cancer
• 2012. Landfeldt E et al. – Patient preferences for characteristics differentiating ovarian stimulation treatments
• 2008. Roux C et al. – Inverse relationship between vertebral fractures and spine osteoarthritis in postmenopausal women with osteoporosis
• 2005. Zöllner YF et al. – Literature review of instruments to assess health-related quality of life during and after menopause

Posters & Presentations

• 2018. SRI Annual Meeting – Quality of Life and Burden of Uterine Fibroids: Results from the First 200 Women Enrolled in a U.S. Real-World Study
• 2017. ASCO Annual Meeting – ENGAGE: Evaluation of a streamlined oncologist-led BRCA mutation (BRCAm) testing and counselling model for patients with ovarian cancer
• 2016. ISPOR European Congress – Health State Utilities for Persistent, Recurrent or Metastatic Cervical Cancer in France
• 2016. ESMO – Evaluating a Novel Oncologist-led BRCA1/2 Mutation (BRCAm) Testing and Counseling Model for Patients with Ovarian cancer: Interim Results from the ENGAGE (NCT02406235) study
• 2016. EUROGIN – Estimating the Management Cost of Cervical Intraepithelial Neoplasia in the UK
• 2016. ISPOR Annual International Meeting – Treatment and Patient Burden in ER+/ HER2-Metastatic Breast Cancer: Results from a Physician Survey in the United States
• 2016. ISPOR Annual International Meeting – Clinical Characteristics, Treatment Patterns and Health Care Utilization in ER+/HER2- Metastatic Postmenopausal Breast Cancer Patients: Results from a Retrospective Medical Record Review in the United States
• 2016. International Symposium on Hereditary Breast and Ovarian Cancer – Evaluating a Novel Oncologist-led BRCA Genetic Testing Counseling Model for Ovarian Cancer Patients: Interim Results from the ENGAGE Study
• 2015. ISPOR European Congress – Patient Characteristics and Disease Burden of Osteoporosis in Post-Menopausal Women at Risk of Fracture in Germany
• 2013. San Antonio Breast Cancer Symposium – Comparative efficacy of everolimus and exemestane versus chemotherapy for advanced breast cancer in terms of progression-free survival
• 2013. ISPOR European Congress – Uterine-Sparing Surgical Treatment Modalities in Women with Uterine Fibroids: A Systematic Review and Indirect Treatment Comparison
• 2012. ECCEO-IOF European Congress – Indirect comparison of bazedoxifene vs. oral bisphophonates for the prevention of nonvertebral fractures in high-risk post-menopausal osteoporosis population
• 2011. ISPOR European Congress – How Do Postmenopausal Women Describe Breast Pain and Breakthrough Bleeding Associated with Hormonal Treatments for Menopausal Symptoms: Qualitative Interviews with Postmenopausal Women in the United States, China, Mexico and Italy.
• 2009. ISPOR European Congress – Item Reduction and Validation of a New Adherence Questionnaire in Osteoporotic Post-Menopausal Women: The Adherence Evaluation of Osteoporosis Treatment (ADEOS) Questionnaire
• 2009. ISPOR European Congress – Symptoms and Impact of Premenstrual Dysphoric Disorder (PMDD). Concepts and Measurement
• 2006. ISPOR European Congress – Cost-Effectiveness of Fulvestrant as an Additional Endocrine Step in the Treatment Sequence for Hormone Responsive Advanced Breast Cancer
• 2006. ISPOR European Congress – Linguistic Validation of the Menstrual Distress Questionnaire (MDQ) in an International Study for a New Combined Oral Contraceptive Pill
• 1999. ISPOR Annual International Meeting – Comparison of Quality of Life Scores between Menopausal Women and Age-Matched Peers
• 1999. ISPOR Annual International Meeting – Implications of Menopausal Symptoms on Quality of Life